Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Eisai

Status: Completed

Conditions: Malignant Glioma

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT02300532

GLI01S

Details and patient eligibility

About

Post-marketing surveillance to investigate the clinical safety and effectiveness in patients of all implantation of Gliadel with malignant glioma in the actual medical setting.

Enrollment: 561 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All-patient of Gliadel implantation

Exclusion criteria

• None

Trial design

561 participants in 1 patient group

Cohort 1

Description:

Patients with diagnosed malignant glioma treated by surgery, implanted Gliadel wafers 7.7mg

Treatment:

Other: No intervention